Parallel Trends in an Unparalleled Pandemic Difference-in-differences for infectious disease policy evaluation
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
Researchers frequently employ difference-in-differences (DiD) to study the impact of public health interventions on infectious disease outcomes. DiD assumes that treatment and non-experimental comparison groups would have moved in parallel in expectation, absent the intervention (“parallel trends assumption”). However, the plausibility of parallel trends assumption in the context of infectious disease transmission is not well-understood. Our work bridges this gap by formalizing epidemiological assumptions required for common DiD specifications, positing an underlying Susceptible-Infectious-Recovered (SIR) data-generating process. We demonstrate that popular specifications can encode strict epidemiological assumptions. For example, DiD modeling incident case numbers or rates as outcomes will produce biased treatment effect estimates unless untreated potential outcomes for treatment and comparison groups come from a data-generating process with the same initial infection and equal transmission rates at each time step. Applying a log transformation or modeling log growth allows for different initial infection rates under an “infinite susceptible population” assumption, but invokes conditions on transmission parameters. We then propose alternative DiD specifications based on epidemiological parameters – the effective reproduction number and the effective contact rate – that are both more robust to differences between treatment and comparison groups and can be extended to complex transmission dynamics. With minimal power difference incidence and log incidence models, we recommend a default of the more robust log specification. Our alternative specifications have lower power than incidence or log incidence models, but have higher power than log growth models. We illustrate implications of our work by re-analyzing published studies of COVID-19 mask policies.
Difference-in-differences is a popular observational study design for policy evaluation. However, it may not perform well when modeling infectious disease outcomes. Although many COVID-19 DiD studies in the medical literature have used incident case numbers or rates as the outcome variable, we demonstrate that this and other common model specifications may encode strict epidemiological assumptions as a result of non-linear infectious disease transmission. We unpack the assumptions embedded in popular DiD specifications assuming a Susceptible-Infected-Recovered data-generating process and propose more robust alternatives, modeling the effective reproduction number and effective contact rate.
Article activity feed
-
Lee Kennedy-Shaffer
Review 2: "Parallel Trends in an Unparalleled Pandemic: Difference-in-Differences for Infectious Disease Policy Evaluation"
Reviewers commend the study for addressing the limitations of standard DiD methods and proposing robust alternatives. They suggest further elaboration on the differences between the new methods and traditional estimates, as well as comparisons to other modeling approaches.
-
Luke J Keele
Review 1: "Parallel Trends in an Unparalleled Pandemic: Difference-in-Differences for Infectious Disease Policy Evaluation"
Reviewers commend the study for addressing the limitations of standard DiD methods and proposing robust alternatives. They suggest further elaboration on the differences between the new methods and traditional estimates, as well as comparisons to other modeling approaches.
-
Strength of evidence
Reviewers: L J Keele (University of Pennsylvania) | 📘📘📘📘📘
L Kennedy-Shaffer (Vassar College) | 📗📗📗📗◻️ -